Biologic therapies in chronic obstructive pulmonary disease: clinical evidence, patient selection, and the path toward precision medicine
Chronic Obstructive Pulmonary Disease (COPD) management has transitioned from a generic treatment model to a precision-medicine approach targeting specific inflammatory endotypes. In